Regulated information

Below you will find all Ipsen documentation related to regulated information.

14 / 11 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 78 kB)
11 / 10 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 78 kB)
19 / 09 / 2017 - Paris (France)
Ipsen receives approval from European Commission for Xermelo® (telotristat ethyl) for the treatment of carcinoid syndrome diarrhea in patients inadequately controlled by somatostatin analogue therapy

Download

 

12 / 09 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 78 kB)
16 / 08 / 2017 - Paris (France)
Exelixis submits U.S. supplemental new drug application for Cabometyx®(Cabozantinib) for the treatment of previously untreated advanced kidney cancer
Download Press Release ( pdf - 210 kB)
15 / 08 / 2017 - Paris (France)
Disclosure of transactions in own shares between 07-07-2017 and 11-08-2017
Download ( pdf - 315 kB)
11 / 08 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 78 kB)
08 / 08 / 2017 - Paris (France)
Disclosure of transactions in own shares between 31-07-2017 and 04-08-2017
Download ( pdf - 558 kB)
01 / 08 / 2017 - Paris (France)
Disclosure of transactions in own shares between 24-07-2017 and 28-07-2017
Download ( pdf - 30 kB)
27 / 07 / 2017 - Paris (France)
Ipsen’s First Half 2017 Financial Results
Télécharger la présentation ( pdf - 523 kB)
25 / 07 / 2017 - Paris (France)
Disclosure of transactions in own shares between 17-07-2017 and 21-07-2017
Download ( pdf - 707 kB)
18 / 07 / 2017 - Paris (France)
Disclosure of transactions in own shares between 10-07-2017 and 14-07-2017
Download ( pdf - 312 kB)
11 / 07 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
30062017_DDroits de vote GB ( pdf - 78 kB)
11 / 07 / 2017 - Paris (France)
Disclosure of transactions in own shares between 03-07-2017 and 07-07-2017
Télécharger ( pdf - 563 kB)
10 / 07 / 2017 - Paris (France)
Disclosure of transactions in own shares between 03-07-2017 and 07-07-2017
Télécharger ( pdf - 562 kB)
10 / 07 / 2017 - Paris (France)
Exelixis and Bristol-Myers Squibb Initiate Phase 3 Trial of Opdivo® in Combination with CABOMETY or Opdivo and Yervoy® in Combination with CABOMETYX, Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma.

 

– First phase 3 trial in a global clinical development program to explore the combination of these agents –

 

– Exelixis, Bristol-Myers Squibb and Ipsen to co-fund this trial –

Download ( pdf - 188 kB)
04 / 07 / 2017 - Paris (France)
Disclosure of transactions in own shares between 26-06-2017 and 30-06-2017
Download ( pdf - 494 kB)
27 / 06 / 2017 - Paris (France)
Disclosure of transactions in own shares between 19-06-2017 and 23-06-2017
Download ( pdf - 87 kB)
21 / 06 / 2017 - Paris (France)
Disclosure of transactions in own shares between 12-06-2017 and 16-06-2017
Télécharger ( pdf - 257 kB)
15 / 06 / 2017 - Paris (France)
Disclosure of transactions in own shares between 05-06-2017 and 09-06-2017
Download ( pdf - 112 kB)
14 / 06 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 76 kB)
17 / 05 / 2017 - Paris (France)
Availability of documentation for the Combined Shareholders’ Meeting of 7 June 2017
Download ( pdf - 284 kB)
10 / 05 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 78 kB)
10 / 04 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
28 / 03 / 2017 - Paris (France)
The Ipsen Group publishes its 2016 Registration Document
Download ( pdf - 173 kB)
01 / 03 / 2017 - Paris (France)
Ipsen’s Partner Lexicon Pharmaceuticals Announces That FDA Approves Lexicon Drug Xermelo™ (Telotristat ethyl) 250 mg as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors.
Download ( pdf - 191 kB)
27 / 02 / 2017 - Paris (France)
Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.
Download ( pdf - 179 kB)
10 / 02 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 29 kB)
10 / 01 / 2017 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
03 / 01 / 2017 - Paris (France)
Disclosure of transactions in own shares between 26-12-2016 and 30-12-2016
Download ( pdf - 305 kB)
28 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 19-12-2016 and 23-12-2016
Download ( pdf - 398 kB)
20 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 12-12-2016 and 16-12-2016
Download ( pdf - 397 kB)
13 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 05-12-2016 and 09-12-2016
Download ( pdf - 21 kB)
09 / 12 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
06 / 12 / 2016 - Paris (France)
Disclosure of transactions in own shares between 28-11-2016 and 02-12-2016
Download ( pdf - 21 kB)
29 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 21-11-2016 and 25-11-2016
Download ( pdf - 373 kB)
22 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 14-11-2016 and 18-11-2016
Download ( pdf - 496 kB)
15 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 07-11-2016 and 11-11-2016
Download ( pdf - 550 kB)
10 / 11 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
08 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 31-10-2016 and 04-11-2016
Download ( pdf - 640 kB)
01 / 11 / 2016 - Paris (France)
Disclosure of transactions in own shares between 24-10-2016 and 28-10-2016
Download ( pdf - 563 kB)
25 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 17-10-2016 and 21-10-2016
Download ( pdf - 392 kB)
18 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 10-10-2016 and 14-10-2016
Download ( pdf - 131 kB)
11 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 03-10-2016 and 07-10-2016
Download ( pdf - 30 kB)
10 / 10 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
04 / 10 / 2016 - Paris (France)
Disclosure of transactions in own shares between 26-09-2016 and 30-09-2016
Download ( pdf - 100 kB)
27 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 19-09-2016 and 23-09-2016
Download ( pdf - 30 kB)
20 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 12-09-2016 and 16-09-2016
Download ( pdf - 253 kB)
13 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 05-09-2016 and 09-09-2016
Download ( pdf - 271 kB)
09 / 09 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 74 kB)
06 / 09 / 2016 - Paris (France)
Disclosure of transactions in own shares between 29-08-2016 and 02-09-2016
Download ( pdf - 419 kB)
30 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 22-08-2016 and 26-08-2016
Download ( pdf - 554 kB)
23 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 15-08-2016 and 19-08-2016
Download ( pdf - 561 kB)
14 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 08-08-2016 and 12-08-2016
Download ( pdf - 506 kB)
05 / 08 / 2016 - Paris (France)
Information regarding the total number of voting rights and shares
Download ( pdf - 75 kB)
05 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 01-08-2016 and 05-08-2016
Download ( pdf - 229 kB)
02 / 08 / 2016 - Paris (France)
Disclosure of transactions in own shares between 25-07-2016 and 29-07-2016
Download ( pdf - 539 kB)
28 / 07 / 2016 - Paris (France)
2016 half year financial report
Download ( pdf - 489 kB)
26 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 18-07-2016 and 22-07-2016
Download ( pdf - 571 kB)
19 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 11-07-2016 and 15-07-2016
Download ( pdf - 651 kB)
12 / 07 / 2016 - Paris (France)
Disclosure of transactions in own shares between 04-07-2016 and 08-07-2016
Download ( pdf - 986 kB)
28 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 21-12-2015 and 24-12-2015
Disclosure of transactions in own shares between 21122015 and 24122015 ( pdf - 151 kB)
22 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 14-12-2015 and 18-12-2015
Disclosure of transactions in own shares between 14122015 and 18122015 ( pdf - 152 kB)
17 / 12 / 2015 - Paris (France)
Ipsen announces its corporate agenda for 2016
17 12 2015 PR Ipsen financial agenda 2016 FINAL ( pdf - 31 kB)
15 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 07-12-2015 and 11-12-2015
Disclosure of transactions in own shares between 07122015 and 11122015 ( pdf - 152 kB)
08 / 12 / 2015 - Paris (France)
Information regarding the total number of voting rights and shares
30112015_DDroits de vote GB ( pdf - 76 kB)
07 / 12 / 2015 - Paris (France)
Disclosure of transactions in own shares between 30-11-2015 and 04-12-2015
Disclosure of transactions in own shares between 30112015 and 04122015 ( pdf - 152 kB)
01 / 12 / 2015 - Paris (France)
Ipsen’s partner Lexicon announced that Telotristat Etiprate had achieved positive top-line results in second phase 3 clinical trial
Telotristat etiprate obtient des premiers résultats positifs dans une deuxième étude clinique de phase 3 ( pdf - 58 kB)
30 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 23/11/2015 and 27/11/2015
Disclosure of transactions in own shares between 23112015 and 27112015 ( pdf - 152 kB)
23 / 11 / 2015 - Paris (France)
Disclosure of transactions in own shares between 16-11-2015 and 20-11-2015
Disclosure of transactions in own shares between 16112015 and 20112015 ( pdf - 48 kB)
19 / 11 / 2015 - Paris (France)
Ipsen and Interprotein enter into a research collaboration for novel peptides in endocrinology
2015 11 19 PR Ipsen Interprotein peptides Cushing endocrinology FINAL ( pdf - 55 kB)
Last update 13/09/2016